A detailed history of Janus Henderson Group PLC transactions in Dexcom Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 556,150 shares of DXCM stock, worth $41.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
556,150
Previous 559,518 0.6%
Holding current value
$41.3 Million
Previous $77.6 Million 18.75%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $371,524 - $473,035
-3,368 Reduced 0.6%
556,150 $63.1 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $1.71 Million - $2.1 Million
-14,999 Reduced 2.61%
559,518 $77.6 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $67 Million - $110 Million
-886,978 Reduced 60.69%
574,517 $71.3 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $6.85 Million - $11 Million
79,556 Added 5.76%
1,461,495 $136 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $68.4 Million - $79.7 Million
608,423 Added 78.66%
1,381,939 $178 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $197 Million - $232 Million
-1,889,968 Reduced 70.96%
773,516 $89.9 Million
Q4 2022

Feb 14, 2023

SELL
$84.98 - $122.67 $189 Million - $273 Million
-2,222,537 Reduced 45.49%
2,663,484 $302 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $92.4 Million - $114 Million
-1,209,707 Reduced 19.85%
4,886,021 $394 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $301 Million - $589 Million
4,432,950 Added 266.6%
6,095,728 $454 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $14.5 Million - $20.1 Million
-154,138 Reduced 8.48%
1,662,778 $851 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $104 Million - $130 Million
-798,824 Reduced 30.54%
1,816,916 $976 Million
Q3 2021

Nov 16, 2021

SELL
$106.71 - $143.18 $27 Million - $36.2 Million
-252,860 Reduced 8.81%
2,615,740 $1.43 Billion
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $81 Million - $108 Million
999,623 Added 53.49%
2,868,600 $1.22 Billion
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $106 Million - $131 Million
1,248,830 Added 201.38%
1,868,977 $672 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $10.3 Million - $13.8 Million
131,724 Added 26.97%
620,147 $229 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $6.26 Million - $7.4 Million
65,528 Added 15.5%
488,423 $201 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $22.7 Million - $38.1 Million
-362,097 Reduced 46.13%
422,895 $171 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $9.52 Million - $15.1 Million
199,106 Added 33.98%
784,992 $211 Million
Q4 2019

Feb 18, 2020

SELL
$36.62 - $57.29 $8.07 Million - $12.6 Million
-220,430 Reduced 27.34%
585,886 $128 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $6.91 Million - $8.52 Million
-194,415 Reduced 19.43%
806,316 $30.1 Million
Q2 2019

Jul 31, 2019

SELL
$27.84 - $38.92 $12.6 Million - $17.6 Million
-451,754 Reduced 31.1%
1,000,731 $150 Million
Q1 2019

Apr 30, 2019

BUY
$28.07 - $38.18 $5.77 Million - $7.84 Million
205,402 Added 16.47%
1,452,485 $173 Million
Q4 2018

Feb 06, 2019

SELL
$26.99 - $37.37 $12.5 Million - $17.3 Million
-464,139 Reduced 27.12%
1,247,083 $149 Million
Q3 2018

Nov 09, 2018

SELL
$23.35 - $36.72 $63.8 Million - $100 Million
-2,731,151 Reduced 61.48%
1,711,222 $245 Million
Q2 2018

Aug 10, 2018

SELL
$17.54 - $25.22 $43.4 Million - $62.4 Million
-2,473,918 Reduced 35.77%
4,442,373 $422 Million
Q1 2018

May 14, 2018

SELL
$13.06 - $18.54 $22.8 Million - $32.4 Million
-1,748,733 Reduced 20.18%
6,916,291 $513 Million
Q4 2017

Feb 09, 2018

SELL
$11.12 - $15.38 $1.72 Million - $2.38 Million
-154,801 Reduced 1.76%
8,665,024 $497 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $22.6 Million - $37.8 Million
1,991,094 Added 29.16%
8,819,825 $0
Q2 2017

Aug 17, 2017

BUY
N/A
6,828,731
6,828,731 $500 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.